Colorimetric detection and chromatographic analyses of designer drugs in biological materials: A comprehensive review

Forensic Toxicology

Volumn 29, Issue 1, 2011, Pages 1-24

  Namera, Akira ^a   Nakamoto, Akihiro ^b   Saito, Takeshi ^c   Nagao, Masataka ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b Forensic Science Laboratory   (Japan)

^c TOKAI UNIVERSITY   (Japan)

Author keywords

Designer drug; GC MS; LC MS( MS); Phenethylamines; Piperazines; Tryptamines

Indexed keywords

BIOMATERIAL; DESIGNER DRUG;

ANALYTIC METHOD; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; COLORIMETRY; DERIVATIZATION; DRUG ISOLATION; DRUG METABOLISM; HYDROLYSIS; IMMUNOCHEMISTRY; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; PRIORITY JOURNAL; REVIEW; STRUCTURE ANALYSIS; TANDEM MASS SPECTROMETRY; THIN LAYER CHROMATOGRAPHY;

EID: 78651069626     PISSN: 18608965     EISSN: 18608973     Source Type: Journal    
DOI: 10.1007/s11419-010-0107-9     Document Type: Review

References (128)

1. T Kraemer HH Maurer 1998 Determination of amphetamine, methamphetamine and amphetamine-derived designer drugs or medicaments in blood and urine J Chromatogr B 713 163 187 1:CAS:528:DyaK1cXjvVSksL8%3D 10.1016/S0378-4347(97) 00515-X (Pubitemid 28346485)
2. OH Drummer 1999 Chromatographic screening techniques in systematic toxicological analysis J Chromatogr B 733 27 45 1:CAS:528:DyaK1MXmvVKhtL8%3D 10.1016/S0378-4347(99)00265-0 (Pubitemid 29481764)
3. M Thevis W Schänzer 2007 Mass spectrometry in sports drug testing: structure characterization and analytical assays Mass Spectrom Rev 26 79 107 1:CAS:528:DC%2BD2sXht1anurw%3D 16888758 10.1002/mas.20107 (Pubitemid 46051814)
4. HH Maurer 2009 Mass spectrometric approaches in impaired driving toxicology Anal Bioanal Chem 393 97 107 1:CAS:528:DC%2BD1cXhsFWisbjL 18759106 10.1007/s00216-008-2338-8 (Pubitemid 50257169)
5. M Takahashi M Nagashima J Suzuki T Seto I Yasuda T Yoshida 2009 Creation and application of psychoactive designer drugs data library using liquid chromatography with photodiode array spectrophotometry detector and gas chromatography-mass spectrometry Talanta 77 1245 1272 1:CAS:528: DC%2BD1cXhsFWisrrM 19084633 10.1016/j.talanta.2008.07.062
6. Shulgin A, Shulgin A (1991) Pihkal: a chemical love story. Transform Press, Berkeley
7. Shulgin A, Shulgin A (1997) Tihkal: the continuation. Transform Press, Berkeley
8. MH Sekera BD Ahrens YC Chang B Starcevic C Georgakopoulos DH Catlin 2005 Another designer steroid: discovery, synthesis, and detection of 'madol' in urine Rapid Commun Mass Spectrom 19 781 784 1:CAS:528:DC%2BD2MXitl2ksbs%3D 15712284 10.1002/rcm.1858 (Pubitemid 40349418)
9. M Thevis H Geyer U Mareck W Schänzer 2005 Screening for unknown synthetic steroids in human urine by liquid chromatography-tandem mass spectrometry J Mass Spectrom 40 955 962 1:CAS:528:DC%2BD2MXnvF2ltLw%3D 15934041 10.1002/jms.873 (Pubitemid 41098082)
10. MW Nielen TF Bovee MC van Engelen P Rutgers AR Hamers JH van Rhijn LR Hoogenboom 2006 Urine testing for designer steroids by liquid chromatography with androgen bioassay detection and electrospray quadrupole time-of-flight mass spectrometry identification Anal Chem 78 424 431 1:CAS:528:DC%2BD2MXht1yrsLbP 16408923 10.1021/ac051317q (Pubitemid 43100373)
11. HF De Brabander K Verheyden V Mortier B Le Bizec W Verbeke D Courtheyn H Noppe 2007 Phytosterols and anabolic agents versus designer drugs Anal Chim Acta 586 49 56 17386696 10.1016/j.aca.2006.07.031 1:CAS:528:DC%2BD2sXhvVyntL4%3D (Pubitemid 46240005)
12. CG Georgakopoulos A Vonaparti M Stamou P Kiousi E Lyris YS Angelis G Tsoupras B Wuest MW Nielen I Panderi M Koupparis 2007 Preventive doping control analysis: liquid and gas chromatography time-of-flight mass spectrometry for detection of designer steroids Rapid Commun Mass Spectrom 21 2439 2446 1:CAS:528:DC%2BD2sXoslKqtLw%3D 17610244 10.1002/rcm.3103 (Pubitemid 47203270)
13. A Vonaparti E Lyris YS Angelis I Panderi M Koupparis A Tsantili-Kakoulidou RJ Peters MW Nielen C Georgakopoulos 2010 Preventive doping control screening analysis of prohibited substances in human urine using rapid-resolution liquid chromatography/high-resolution time-of-flight mass spectrometry Rapid Commun Mass Spectrom 24 1595 1609 1:CAS:528: DC%2BC3cXmt12ls74%3D 20486255 10.1002/rcm.4554
14. RB Rothman JR Glowa 1995 A review of the effects of dopaminergic agents on humans, animals, and drug-seeking behavior, and its implications for medication development. Focus on GBR 12909 Mol Neurobiol 11 1 19 1:CAS:528:DyaK2MXpsl2lu70%3D 8561954 10.1007/BF02740680
15. B Giros M Jaber SR Jones RM Wightman MG Caron 1996 Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter Nature 379 606 612 1:CAS:528:DyaK28XhtFKrurg%3D 8628395 10.1038/379606a0 (Pubitemid 26052818)
16. RB Rothman MH Baumann CM Dersch DV Romero KC Rice FI Carroll JS Partilla 2001 Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin Synapse 39 32 41 1:CAS:528:DC%2BD3cXovFahsLg%3D 11071707 10.1002/1098-2396(20010101)39:1<32:: AID-SYN5>3.0.CO;2-3
17. RA Lyon RA Glennon M Titeler 1986 3, 4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors Psychopharmacology 88 525 526 1:CAS:528:DyaL28XltVygs70%3D 2871581 10.1007/BF00178519
18. G Rudnick SC Wall 1992 The molecular mechanism of "ecstasy" [3, 4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release Proc Natl Acad Sci USA 89 1817 1821 1:CAS:528:DyaK38XhvVOqsL4%3D 1347426 10.1073/pnas.89.5.1817
19. AP Monte D Marona-Lewicka MA Parker DB Wainscott DL Nelson DE Nichols 1996 Dihydrobenzofuran analogues of hallucinogens. 3. Models of 4-substituted (2,5-dimethoxyphenyl)alkylamine derivatives with rigidified methoxy groups J Med Chem 39 2953 2961 1:CAS:528:DyaK28XjvVartbY%3D 8709129 10.1021/jm960199j (Pubitemid 26251033)
20. RB Rothman MH Baumann 2002 Therapeutic and adverse actions of serotonin transporter substrates Pharmacol Ther 95 73 88 1:CAS:528:DC%2BD38XmtVWltr8%3D 12163129 10.1016/S0163-7258(02)00234-6
21. DE Nichols 1986 Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens J Psychoact Drugs 18 305 313 1:CAS:528:DyaL2sXhtlWjtL4%3D
22. C Sogawa N Sogawa J Tagawa A Fujino K Ohyama M Asanuma M Funada S Kitayama 2007 5-Methoxy-N,N-diisopropyltryptamine (Foxy), a selective and high affinity inhibitor of serotonin transporter Toxicol Lett 170 75 82 1:CAS:528:DC%2BD2sXjslGktbo%3D 17382495 10.1016/j.toxlet.2007.02.007 (Pubitemid 46498906)
23. WE Fantegrossi AW Harrington CL Kiessel JR Eckler RA Rabin JC Winter A Coop KC Rice JH Woods 2006 Hallucinogen-like actions of 5-methoxy-N,N- diisopropyltryptamine in mice and rats Pharmacol Biochem Behav 83 122 129 1:CAS:528:DC%2BD28Xit1aqsbY%3D 16460788 10.1016/j.pbb.2005.12.015
24. F Nagai R Nonaka H Satoh K Kamimura 2007 The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain Eur J Pharmacol 559 132 137 1:CAS:528:DC%2BD2sXisVWgu7g%3D 17223101 10.1016/j.ejphar.2006.11.075 (Pubitemid 46295399)
25. T Nakagawa S Kaneko 2008 Neuropsychotoxicity of abused drugs: molecular and neural mechanisms of neuropsychotoxicity induced by methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), and 5-methoxy-N,N- diisopropyltryptamine (foxy) J Pharmacol Sci 106 2 8 1:CAS:528: DC%2BD1cXhslGntbw%3D 18198474 10.1254/jphs.FM0070141 (Pubitemid 351159062)
26. T Kraemer HH Maurer 2002 Toxicokinetics of amphetamines: metabolism and toxicokinetic data of designer drugs, amphetamine, methamphetamine, and their N-alkyl derivatives Ther Drug Monit 24 277 289 1:CAS:528:DC%2BD38XivVyjur0%3D 11897973 10.1097/00007691-200204000-00009 (Pubitemid 34248035)
27. HH Maurer T Kraemer D Springer RF Staack 2004 Chemistry, pharmacology, toxicology, and hepatic metabolism of designer drugs of the amphetamine (ecstasy), piperazine, and pyrrolidinophenone types: a synopsis Ther Drug Monit 26 127 131 1:CAS:528:DC%2BD2cXjvFOktbw%3D 15228152 10.1097/00007691-200404000- 00007 (Pubitemid 38501205)
28. RF Staack HH Maurer 2005 Metabolism of designer drugs of abuse Curr Drug Metab 6 259 274 1:CAS:528:DC%2BD2MXkvF2isL4%3D 15975043 10.2174/1389200054021825 (Pubitemid 40753856)
29. MR Meyer HH Maurer 2010 Metabolism of designer drugs of abuse: an updated review Curr Drug Metab 11 468 482 1:CAS:528:DC%2BC3cXhtVejurzN 20540700 10.2174/138920010791526042
30. BR Sitaram L Lockett R Talomsin GL Blackman WR McLeod 1987 In vivo metabolism of 5-methoxy-N,N-dimethyltryptamine and N,N-dimethyltryptamine in the rat Biochem Pharmacol 36 1509 1512 1:CAS:528:DyaL2sXkvV2hsL4%3D 3472526 10.1016/0006-2952(87)90118-3 (Pubitemid 17079563)
31. R Meatherall P Sharma 2003 Foxy, a designer tryptamine hallucinogen J Anal Toxicol 27 313 317 1:CAS:528:DC%2BD3sXlsVSkt78%3D 12908946
32. JM Wilson F McGeorge S Smolinske R Meatherall 2005 A foxy intoxication Forensic Sci Int 148 31 36 1:CAS:528:DC%2BD2cXhtVyrtb%2FE 15607587 10.1016/j.forsciint.2004.04.017 (Pubitemid 40029393)
33. T Kamata M Katagi HT Kamata A Miki N Shima K Zaitsu M Nishikawa E Tanaka K Honda H Tsuchihashi 2006 Metabolism of the psychotomimetic tryptamine derivative 5-methoxy-N,N-diisopropyltryptamine in humans: identification and quantification of its urinary metabolites Drug Metab Dispos 34 281 287 1:CAS:528:DC%2BD28XhtVCntbY%3D 16280455 10.1124/dmd.105.005835 (Pubitemid 43145029)
34. T Kamata M Katagi H Tsuchihashi 2010 Metabolism and toxicological analyses of hallucinogenic tryptamine analogues being abused in Japan Forensic Toxicol 28 1 8 1:CAS:528:DC%2BC3cXhtleit74%3D 10.1007/s11419-009-0087-9
35. TA Dal Cason 1997 The characterization of some 3,4- methylenedioxycathinone (MDCATH) homologs Forensic Sci Int 87 9 53 1:CAS:528:DyaK2sXkslagurc%3D 10.1016/S0379-0738(97)02133-6 (Pubitemid 27292471)
36. K Matsuda T Fukuzawa Y Ishii H Yamada 2007 Color reaction of 3,4-methylenedioxyamphetamines with chromotropic acid: its improvement and application to the screening of seized tablets Forensic Toxicol 25 37 40 1:CAS:528:DC%2BD2sXotleksLk%3D 10.1007/s11419-007-0022-x (Pubitemid 46855432)
37. A Nakamoto A Namera M Yahata T Kuramoto M Nishida M Yashiki 2007 A systematic toxicological analysis for hallucinogenic tryptamines in seized and biological materials (in Japanese with English abstract) Hiroshima Igaku Zasshi 55 1 14 1:CAS:528:DC%2BD2sXotFaru74%3D
38. N Uchiyama M Kawamura H Kamakura R Kikura-Hanajiri Y Goda 2008 Analytical data of designated substances (Shitei-Yakubutsu) controlled by the Pharmaceutical Affairs Law in Japan, part II: color test and TLC (in Japanese with English abstract) Yakugaku Zasshi 128 981 987 1:CAS:528:DC%2BD1cXhtVylsrrJ 18520145 10.1248/yakushi.128.981 (Pubitemid 351841510)
39. M Takahashi M Nagashima J Suzuki T Seto I Yasuda T Yoshida 2008 Analysis of phenethylamines and tryptamines in designer drugs using gas chromatography-mass spectrometry J Health Sci 54 89 96 1:CAS:528: DC%2BD1cXisFGgsr8%3D 10.1248/jhs.54.89 (Pubitemid 351757446)
40. K Kudo T Ishida W Hikiji M Hayashida K Uekusa Y Usumoto A Tsuji N Ikeda 2009 Construction of calibration-locking databases for rapid and reliable drug screening by gas chromatography-mass spectrometry Forensic Toxicol 27 21 31 1:CAS:528:DC%2BD1MXitlGgtLs%3D 10.1007/s11419-009-0066-1
41. T Ishida K Kudo H Inoue A Tsuji T Kojima N Ikeda 2006 Rapid screening for and simultaneous semiquantitative analysis of thirty abused drugs in human urine samples using gas chromatography-mass spectrometry J Anal Toxicol 30 468 477 1:CAS:528:DC%2BD28XoslGltLs%3D 16959141
42. SP Vorce JH Sklerov 2004 A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS J Anal Toxicol 28 407 410 1:CAS:528:DC%2BD2cXnsVehtLY%3D 15516287
43. FT Peters S Schaefer RF Staack T Kraemer HH Maurer 2003 Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry J Mass Spectrom 38 659 676 1:CAS:528: DC%2BD3sXltlSksL4%3D 12827635 10.1002/jms.483 (Pubitemid 36818224)
44. K Zaitsu M Katagi H Kamata K Nakanishi N Shima T Kamata H Nishioka A Miki M Tatsuno H Tsuchihashi 2010 Simultaneous analysis of six novel hallucinogenic (tetrahydrobenzodifuranyl)aminoalkanes (FLYs) and (benzodifuranyl)aminoalkanes (DragonFLYs) by GC-MS, LC-MS, and LC-MS-MS Forensic Toxicol 28 9 18 1:CAS:528:DC%2BC3cXhtleit78%3D 10.1007/s11419-009-0083-0
45. K Tsujikawa K Kuwayama H Miyaguchi T Kanamori YT Iwata H Inoue 2010 Increase in split ratio enables detection of underivatized N-hydroxy-3,4- methylenedioxymethamphetamine and N-hydroxy-3,4-methylenedioxyamphetamine by capillary GC-MS Forensic Toxicol 28 55 57 10.1007/s11419-009-0082-1
46. MR Meyer J Wilhelm FT Peters HH Maurer 2010 Beta-keto amphetamines: studies on the metabolism of the designer drug mephedrone and toxicological detection of mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry Anal Bioanal Chem 397 1225 1233 1:CAS:528:DC%2BC3cXjsleltrc%3D 20333362 10.1007/s00216-010-3636-5
47. F Westphal P Rösner T Junge 2010 Differentiation of regioisomeric ring-substituted fluorophenethylamines with product ion spectrometry Forensic Sci Int 194 53 59 1:CAS:528:DC%2BD1MXhs1Wisr%2FN 19900772 10.1016/j.forsciint. 2009.10.007
48. A Camilleri MR Johnston M Brennan S Davis DG Caldicott 2010 Chemical analysis of four capsules containing the controlled substance analogues 4-methylmethcathinone, 2-fluoromethamphetamine, α-phthalimidopropiophenone and N-ethylcathinone Forensic Sci Int 197 59 66 1:CAS:528:DC%2BC3cXktVWktro%3D 20074881 10.1016/j.forsciint.2009.12.048
49. C Sauer FT Peters C Haas MR Meyer G Fritschi HH Maurer 2009 New designer drug α-pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques J Mass Spectrom 44 952 964 1:CAS:528: DC%2BD1MXosVCmtrs%3D 19241365 10.1002/jms.1571
50. H Fujii K Hara M Kageura M Kashiwagi A Matsusue S Kubo 2009 High throughput chiral analysis of urinary amphetamines by GC-MS using a short narrow-bore capillary column Forensic Toxicol 27 75 80 1:CAS:528: DC%2BD1MXos1Chu7Y%3D 10.1007/s11419-009-0073-2
51. M Rohanova M Balikova 2009 Studies on distribution and metabolism of p-methoxymethamphetamine (PMMA) in rats after subcutaneous administration Toxicology 259 61 68 1:CAS:528:DC%2BD1MXktF2nsLw%3D 19428944 10.1016/j.tox.2009.02.003
52. MF Andreasen R Telving RI Birkler B Schumacher M Johannsen 2009 A fatal poisoning involving Bromo-Dragonfly Forensic Sci Int 183 91 96 1:CAS:528:DC%2BD1MXjvFentw%3D%3D 19091499 10.1016/j.forsciint.2008.11.001
53. RP Archer 2009 Fluoromethcathinone, a new substance of abuse Forensic Sci Int 185 10 20 1:CAS:528:DC%2BD1MXit1Shtrw%3D 19195800 10.1016/j.forsciint.2008. 11.013
54. K Zaitsu M Katagi HT Kamata T Kamata N Shima A Miki H Tsuchihashi Y Mori 2009 Determination of the metabolites of the new designer drugs bk-MBDB and bk-MDEA in human urine Forensic Sci Int 188 131 139 1:CAS:528: DC%2BD1MXmtlKgsL8%3D 19406592 10.1016/j.forsciint.2009.04.001
55. F Westphal T Junge P Rösner F Sönnichsen F Schuster 2009 Mass and NMR spectroscopic characterization of 3,4-methylenedioxypyrovalerone: a designer drug with α-pyrrolidinophenone structure Forensic Sci Int 190 1 8 1:CAS:528:DC%2BD1MXovF2qtbw%3D 19500924 10.1016/j.forsciint.2009.05.001
56. S Strano-Rossi F Botrè AM Bermejo MJ Tabernero 2009 A rapid method for the extraction, enantiomeric separation and quantification of amphetamines in hair Forensic Sci Int 193 95 100 1:CAS:528:DC%2BD1MXhsVGnt7%2FJ 19896309 10.1016/j.forsciint.2009.09.016
57. K Zaitsu M Katagi HT Kamata A Miki H Tsuchihashi 2008 Discrimination and identification of regioisomeric β-keto analogues of 3,4- methylenedioxyamphetamines by gas chromatography-mass spectrometry Forensic Toxicol 26 45 51 1:CAS:528:DC%2BD1MXotFKqsA%3D%3D 10.1007/s11419-008-0050-1
58. K Kanai K Takekawa T Kumamoto T Ishikawa T Ohmori 2008 Simultaneous analysis of six phenethylamine-type designer drugs by TLC, LC-MS, and GC-MS Forensic Toxicol 26 6 12 1:CAS:528:DC%2BD1cXptFyhsbw%3D 10.1007/s11419-008-0041- 2
59. K Zaitsu M Katagi H Kamata T Kamata N Shima A Miki T Iwamura H Tsuchihashi 2008 Discrimination and identification of the six aromatic positional isomers of trimethoxyamphetamine (TMA) by gas chromatography-mass spectrometry (GC-MS) J Mass Spectrom 43 528 534 1:CAS:528:DC%2BD1cXltlWktLo%3D 18035853 10.1002/jms.1347 (Pubitemid 351518674)
60. AH Ewald D Ehlers HH Maurer 2008 Metabolism and toxicological detection of the designer drug 4-chloro-2,5-dimethoxyamphetamine in rat urine using gas chromatography-mass spectrometry Anal Bioanal Chem 390 1837 1842 1:CAS:528:DC%2BD1cXjsFWrsrk%3D 18259731 10.1007/s00216-008-1917-z
61. AH Ewald M Puetz HH Maurer 2008 Designer drug 2,5-dimethoxy-4-methyl- amphetamine (DOM, STP): involvement of the cytochrome P450 isoenzymes in formation of its main metabolite and detection of the latter in rat urine as proof of a drug intake using gas chromatography-mass spectrometry J Chromatogr B 862 252 256 1:CAS:528:DC%2BD1cXhsVOlsLs%3D 10.1016/j.jchromb.2007.11.042
62. K Zaitsu M Katagi T Kamata H Kamata N Shima H Tsuchihashi T Hayashi H Kuroki R Matoba 2008 Determination of a newly encountered designer drug "p-methoxyethylamphetamine" and its metabolites in human urine and blood Forensic Sci Int 177 77 84 1:CAS:528:DC%2BD1cXktV2jsb8%3D 18155375 10.1016/j.forsciint.2007.11.001
63. K Kudo T Ishida K Hara S Kashimura A Tsuji N Ikeda 2007 Simultaneous determination of 13 amphetamine related drugs in human whole blood using an enhanced polymer column and gas chromatography-mass spectrometry J Chromatogr B 855 115 120 1:CAS:528:DC%2BD2sXotVGnu7k%3D 10.1016/j.jchromb.2007.03.002 (Pubitemid 47077727)
64. F Westphal T Junge P Rösner G Fritschi B Klein U Girreser 2007 Mass spectral and NMR spectral data of two new designer drugs with an α-aminophenone structure: 4′-methyl-α-pyrrolidinohexanophenone and 4′-methyl-α-pyrrolidinobutyrophenone Forensic Sci Int 169 32 42 1:CAS:528:DC%2BD2sXlt1amuro%3D 16962275 10.1016/j.forsciint.2006.07.024 (Pubitemid 46711226)
65. JL da Costa AY Wang GA Micke AO Maldaner RL Romano HA Martins-Júnior O Negrini Neto MF Tavares 2007 Chemical identification of 2,5-dimethoxy-4-bromoamphetamine (DOB) Forensic Sci Int 173 130 136 17376619 10.1016/j.forsciint.2007.02.018 1:CAS:528:DC%2BD2sXhtF2rtrjK (Pubitemid 47588741)
66. R Kikura-Hanajiri M Kawamura K Saisho Y Kodama Y Goda 2007 The disposition into hair of new designer drugs; methylone, MBDB and methcathinone J Chromatogr B 855 121 126 1:CAS:528:DC%2BD2sXovFOqsrs%3D 10.1016/j.jchromb.2007. 05.018 (Pubitemid 47212020)
67. DS Theobald G Fritschi HH Maurer 2007 Studies on the toxicological detection of the designer drug 4-bromo-2,5-dimethoxy-β-phenethylamine (2C-B) in rat urine using gas chromatography-mass spectrometry J Chromatogr B 846 374 377 1:CAS:528:DC%2BD2sXhtVKgt78%3D 10.1016/j.jchromb.2006.08.049 (Pubitemid 46149509)
68. AH Ewald G Fritschi HH Maurer 2007 Metabolism and toxicological detection of the designer drug 4-iodo-2,5-dimethoxy-amphetamine (DOI) in rat urine using gas chromatography-mass spectrometry J Chromatogr B 857 170 174 1:CAS:528:DC%2BD2sXhtVWmsLrE 10.1016/j.jchromb.2007.06.027 (Pubitemid 47362858)
69. M Yahata A Namera M Nishida M Yashiki T Kuramoto K Kimura 2006 In-matrix derivatization and automated headspace solid-phase microextraction for GC-MS determination of amphetamine-related drugs in human hair Forensic Toxicol 24 51 57 1:CAS:528:DC%2BD2sXhvVantr8%3D 10.1007/s11419-006-0010-6 (Pubitemid 46020946)
70. DS Theobald HH Maurer 2006 Studies on the metabolism and toxicological detection of the designer drug 2,5-dimethoxy-4-methyl-β-phenethylamine (2C-D) in rat urine using gas chromatographic/mass spectrometric techniques J Mass Spectrom 41 1509 1519 1:CAS:528:DC%2BD28XhtlWqs7bE 17103384 10.1002/jms.1128 (Pubitemid 44875661)
71. DS Theobald M Pütz E Schneider HH Maurer 2006 New designer drug 4-iodo-2,5-dimethoxy-β-phenethylamine (2C-I): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric and capillary electrophoretic/mass spectrometric techniques J Mass Spectrom 41 872 886 1:CAS:528:DC%2BD28XnslCgtLY%3D 16810648 10.1002/jms.1045 (Pubitemid 44106048)
72. DS Theobald HH Maurer 2006 Studies on the metabolism and toxicological detection of the designer drug 4-ethyl-2,5-dimethoxy-β-phenethylamine (2C-E) in rat urine using gas chromatographic-mass spectrometric techniques J Chromatogr B 842 76 90 1:CAS:528:DC%2BD28XpvFegsbc%3D 10.1016/j.jchromb.2006.03. 001 (Pubitemid 44416629)
73. P Rösner B Quednow U Girreser T Junge 2005 Isomeric fluoro-methoxy-phenylalkylamines: a new series of controlled-substance analogues (designer drugs) Forensic Sci Int 148 143 156 15639609 10.1016/j.forsciint. 2004.05.003 1:CAS:528:DC%2BD2MXitFegsA%3D%3D (Pubitemid 40082404)
74. KL Klette MH Jamerson CL Morris-Kukoski AR Kettle JJ Snyder 2005 Rapid simultaneous determination of amphetamine, methamphetamine, 3,4- methylenedioxyamphetamine, 3,4-methylenedioxymethamphetamine, and 3,4-methylenedioxyethylamphetamine in urine by fast gas chromatography-mass spectrometry J Anal Toxicol 29 669 674 1:CAS:528:DC%2BD2MXhtFChsL%2FM 16419398
75. E Han W Yang J Lee Y Park E Kim M Lim H Chung 2005 The prevalence of MDMA/MDA in both hair and urine in drug users Forensic Sci Int 152 73 77 1:CAS:528:DC%2BD2MXltFejtrY%3D 15939177 10.1016/j.forsciint.2005.03.010 (Pubitemid 40804504)
76. FT Peters MR Meyer G Fritschi HH Maurer 2005 Studies on the metabolism and toxicological detection of the new designer drug 4′-methyl-α- pyrrolidinobutyrophenone (MPBP) in rat urine using gas chromatography-mass spectrometry J Chromatogr B 824 81 91 1:CAS:528:DC%2BD2MXpslyntbs%3D 10.1016/j.jchromb.2005.07.003 (Pubitemid 41215584)
77. AH Ewald FT Peters M Weise HH Maurer 2005 Studies on the metabolism and toxicological detection of the designer drug 4-methylthioamphetamine (4-MTA) in human urine using gas chromatography-mass spectrometry J Chromatogr B 824 123 131 1:CAS:528:DC%2BD2MXpslynsbo%3D 10.1016/j.jchromb.2005.07.007 (Pubitemid 41215589)
78. H Carmo D de Boer F Remião F Carvalho LA dos Reys M de Lourdes Bastos 2004 Metabolism of the designer drug 4-bromo-2, 5-dimethoxyphenethylamine (2C-B) in mice, after acute administration J Chromatogr B 811 143 152 1:CAS:528:DC%2BD2cXptFKrtbo%3D
79. RF Staack J Fehn HH Maurer 2003 New designer drug p- methoxymethamphetamine: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry J Chromatogr B 789 27 41 1:CAS:528:DC%2BD3sXjt1Grt7w%3D 10.1016/S1570-0232(02)01018-8 (Pubitemid 36513784)
80. D Springer FT Peters G Fritschi HH Maurer 2003 New designer drug 4′-methyl-α-pyrrolidinohexanophenone: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry J Chromatogr B 789 79 91 1:CAS:528:DC%2BD3sXjt1Grt7k%3D 10.1016/S1570-0232(03) 00043-6 (Pubitemid 36513789)
81. D Springer G Fritschi HH Maurer 2003 Metabolism and toxicological detection of the new designer drug 4′-methoxy-α- pyrrolidinopropiophenone studied in rat urine using gas chromatography-mass spectrometry J Chromatogr B 793 331 342 1:CAS:528:DC%2BD3sXlvFGiu7Y%3D 10.1016/S1570-0232(03)00334-9 (Pubitemid 37271973)
82. D Springer G Fritschi HH Maurer 2003 Metabolism and toxicological detection of the new designer drug 3′,4′-methylenedioxy-α- pyrrolidinopropiophenone studied in urine using gas chromatography-mass spectrometry J Chromatogr B 793 377 388 1:CAS:528:DC%2BD3sXlvFGhsr0%3D 10.1016/S1570-0232(03)00350-7 (Pubitemid 37271978)
83. D Springer G Fritschi HH Maurer 2003 Metabolism of the new designer drug α-pyrrolidinopropiophenone (PPP) and the toxicological detection of PPP and 4'-methyl-α-pyrrolidinopropiophenone (MPPP) studied in rat urine using gas chromatography-mass spectrometry J Chromatogr B 796 253 266 1:CAS:528:DC%2BD3sXosVyisbo%3D 10.1016/j.jchromb.2003.07.008 (Pubitemid 37329670)
84. F Musshoff DW Lachenmeier L Kroener B Madea 2002 Automated headspace solid-phase dynamic extraction for the determination of amphetamines and synthetic designer drugs in hair samples J Chromatogr A 958 231 238 1:CAS:528:DC%2BD38XktVCht74%3D 12134820 10.1016/S0021-9673(02)00317-5 (Pubitemid 34556951)
85. D Springer FT Peters G Fritschi HH Maurer 2002 Studies on the metabolism and toxicological detection of the new designer drug 4′-methyl-α- pyrrolidinopropiophenone in urine using gas chromatography-mass spectrometry J Chromatogr B 773 25 33 1:CAS:528:DC%2BD38XltVGltLY%3D 10.1016/S1570-0232(01) 00578-5 (Pubitemid 34518267)
86. HH Maurer J Bickeboeller-Friedrich T Kraemer FT Peters 2000 Toxicokinetics and analytical toxicology of amphetamine-derived designer drugs ('Ecstasy') Toxicol Lett 112-113 133 142 10720722 10.1016/S0378-4274(99)00207-6 (Pubitemid 30138114)
87. HK Ensslin KA Kovar HH Maurer 1996 Toxicological detection of the designer drug 3,4-methylenedioxyethylamphetamine (MDE, "Eve") and its metabolites in urine by gas chromatography-mass spectrometry and fluorescence polarization immunoassay J Chromatogr B 683 189 197 1:CAS:528:DyaK28XmtFektL4%3D 10.1016/0378-4347(96)00129-6 (Pubitemid 26319562)
88. A Nakamoto A Namera M Nishida M Yashiki T Kuramoto K Kimura 2007 Identification and quantitative determination of 5-methoxy-N,N-di-n- propyltryptamine in urine by isotope dilution gas chromatography-mass spectrometry Forensic Toxicol 25 1 7 1:CAS:528:DC%2BD2sXotleksLw%3D 10.1007/s11419-006-0018-y (Pubitemid 46855428)
89. M Itokawa K Iwata M Takahashi G Sugihara T Sasaki Y Abe M Uno M Hobo D Jitoku K Inoue M Arai I Yasuda M Shintani 2007 Acute confusional state after designer tryptamine abuse Psychiatry Clin Neurosci 61 196 199 1:CAS:528:DC%2BD2sXkvFOlu7w%3D 17362440 10.1111/j.1440-1819.2007.01638.x (Pubitemid 46365268)
90. F Westphal T Junge U Girreser S Stobbe SB Pérez 2009 Structure elucidation of a new designer benzylpiperazine: 4-bromo-2,5- dimethoxybenzylpiperazine Forensic Sci Int 187 87 96 1:CAS:528: DC%2BD1MXkslKrsLk%3D 19345524 10.1016/j.forsciint.2009.03.003
91. H Tsutsumi M Katagi A Miki N Shima T Kamata M Nishikawa K Nakajima H Tsuchihashi 2005 Development of simultaneous gas chromatography-mass spectrometric and liquid chromatography-electrospray ionization mass spectrometric determination method for the new designer drugs, N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)piperazine (TFMPP) and their main metabolites in urine J Chromatogr B 819 315 322 1:CAS:528: DC%2BD2MXjtF2hurs%3D 10.1016/j.jchromb.2005.02.016 (Pubitemid 40521967)
92. RF Staack HH Maurer 2003 Piperazine-derived designer drug 1-(3-chlorophenyl)piperazine (mCPP): GC-MS studies on its metabolism and its toxicological detection in rat urine including analytical differentiation from its precursor drugs trazodone and nefazodone J Anal Toxicol 27 560 568 1:CAS:528:DC%2BD3sXoslOju78%3D 14670134
93. RF Staack HH Maurer 2003 Toxicological detection of the new designer drug 1-(4-methoxyphenyl)piperazine and its metabolites in urine and differentiation from an intake of structurally related medicaments using gas chromatography-mass spectrometry J Chromatogr B 798 333 342 1:CAS:528:DC%2BD3sXpt1SrurY%3D 10.1016/j.jchromb.2003.10.004 (Pubitemid 37487734)
94. RF Staack G Fritschi HH Maurer 2002 Studies on the metabolism and toxicological detection of the new designer drug N-benzylpiperazine in urine using gas chromatography-mass spectrometry J Chromatogr B 773 35 46 1:CAS:528:DC%2BD38XltVGltLc%3D 10.1016/S1570-0232(01)00619-5 (Pubitemid 34518268)
95. D de Boer IJ Bosman E Hidvégi C Manzoni AA Benkö LJ dos Reys RA Maes 2001 Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market Forensic Sci Int 121 47 56 11516887 10.1016/S0379- 0738(01)00452-2 (Pubitemid 32758813)
96. S Sato S Suzuki XP Lee K Sato 2010 Studies on 1-(2-phenethyl)-4-(N- propionylanilino)piperidine (fentanyl) and related compounds VII. Quantification of α-methylfentanyl metabolites excreted in rat urine Forensic Sci Int 195 68 72 1:CAS:528:DC%2BC3cXhtlGjs7w%3D 20005651 10.1016/j.forsciint.2009.11. 014
97. C Sauer FT Peters RF Staack G Fritschi HH Maurer 2008 New designer drugs N-(1-phenylcyclohexyl)-2-ethoxyethanamine (PCEEA) and N-(1-phenylcyclohexyl)-2- methoxyethanamine (PCMEA): studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques J Mass Spectrom 43 305 316 1:CAS:528:DC%2BD1cXjvVahs7w%3D 17968862 10.1002/jms.1312 (Pubitemid 351373931)
98. C Sauer FT Peters RF Staack G Fritschi HH Maurer 2008 Metabolism and toxicological detection of the designer drug N-(1-phenylcyclohexyl)-3- methoxypropanamine (PCMPA) in rat urine using gas chromatography-mass spectrometry Forensic Sci Int 181 47 51 1:CAS:528:DC%2BD1cXhtlans7zN 18922655 10.1016/j.forsciint.2008.09.001
99. C Sauer FT Peters RF Staack G Fritschi HH Maurer 2008 Metabolism and toxicological detection of a new designer drug, N-(1-phenylcyclohexyl) propanamine, in rat urine using gas chromatography-mass spectrometry J Chromatogr A 1186 380 390 1:CAS:528:DC%2BD1cXjtlKitL0%3D 18035363 10.1016/j.chroma.2007.11.002 (Pubitemid 351375218)
100. N Uchiyama R Kikura-Hanajiri J Ogata Y Goda 2010 Chemical analysis of synthetic cannabinoids as designer drugs in herbal products Forensic Sci Int 198 31 38 1:CAS:528:DC%2BC3cXltF2nu7c%3D 20117892 10.1016/j.forsciint.2010.01.004
101. N Uchiyama R Kikura-Hanajiri N Kawahara Y Goda 2009 Identification of a cannabimimetic indole as a designer drug in a herbal product Forensic Toxicol 27 61 66 1:CAS:528:DC%2BD1MXos1Cgsrs%3D 10.1007/s11419-009-0069-y
102. A Wohlfarth W Weinmann S Dresen 2010 LC-MS/MS screening method for designer amphetamines, tryptamines, and piperazines in serum Anal Bioanal Chem 396 2403 2414 1:CAS:528:DC%2BC3cXltVCqtQ%3D%3D 20069283 10.1007/s00216-009-3394- 4
103. S Pichini M Pujadas E Marchei M Pellegrini J Fiz R Pacifici P Zuccaro M Farré R de la Torre 2008 Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of "hallucinogenic designer drugs" in urine of consumers J Pharm Biomed Anal 47 335 342 1:CAS:528:DC%2BD1cXlslylt70%3D 18262381 10.1016/j.jpba.2007.12.039
104. M Concheiro A de Castro O Quintela M López-Rivadulla A Cruz 2006 Determination of drugs of abuse and their metabolites in human plasma by liquid chromatography-mass spectrometry. An application to 156 road fatalities J Chromatogr B 832 81 89 1:CAS:528:DC%2BD28Xhtlart7g%3D 10.1016/j.jchromb.2005.12. 047 (Pubitemid 43213013)
105. R Kikura-Hanajiri M Kawamura A Miyajima M Sunouchi Y Goda 2010 Determination of a new designer drug, N-hydroxy-3,4- methylenedioxymethamphetamine and its metabolites in rats using ultra-performance liquid chromatography-tandem mass spectrometry Forensic Sci Int 198 62 69 1:CAS:528:DC%2BC3cXltF2msrc%3D 20299167 10.1016/j.forsciint.2010. 02.013
106. M Nieddu G Boatto MA Pirisi E Baralla 2009 Multi-residue analysis of eight thioamphetamine designer drugs in human urine by liquid chromatography/tandem mass spectrometry Rapid Commun Mass Spectrom 23 3051 3056 1:CAS:528:DC%2BD1MXhtV2ltLfL 19705383 10.1002/rcm.4219
107. MJ Tabernero ML Felli AM Bermejo M Chiarotti 2009 Determination of ketamine and amphetamines in hair by LC/MS/MS Anal Bioanal Chem 395 2547 2557 1:CAS:528:DC%2BD1MXht1ajtr%2FL 19806348 10.1007/s00216-009-3163-4
108. N Shima M Katagi H Kamata K Zaitsu T Kamata A Miki H Tsuchihashi T Sakuma N Nemoto 2008 Conjugates of p-hydroxymethamphetamine and 4-hydroxy-3- methoxymethamphetamine in blood obtained from methamphetamine and 3,4-methylenedioxymethamphetamine users: analysis by LC-MS-MS Forensic Toxicol 26 58 65 1:CAS:528:DC%2BD1MXotFKqtg%3D%3D 10.1007/s11419-008-0054-x
109. M Nieddu G Boatto MA Pirisi E Azara M Marchetti 2008 LC-MS analysis of trimethoxyamphetamine designer drugs (TMA series) from urine samples J Chromatogr B 867 126 130 1:CAS:528:DC%2BD1cXls1Snsrk%3D 10.1016/j.jchromb.2008. 03.027
110. N Shima H Kamata M Katagi H Tsuchihashi T Sakuma N Nemoto 2007 Direct determination of glucuronide and sulfate of 4-hydroxy-3-methoxymethamphetamine, the main metabolite of MDMA, in human urine J Chromatogr B 857 123 129 1:CAS:528:DC%2BD2sXhtVWmsLrM 10.1016/j.jchromb.2007.07.003 (Pubitemid 47364837)
111. M Kłys S Rojek K Woźniak E Rzepecka-Woźniak 2007 Fatality due to the use of a designer drug MDMA (Ecstasy) Legal Med 9 185 191 17320458 10.1016/j.legalmed.2006.12.004 1:CAS:528:DC%2BD2sXmtVejtLo%3D (Pubitemid 46818090)
112. MJ Bogusz KD Krüger RD Maier 2000 Analysis of underivatized amphetamines and related phenethylamines with high-performance liquid chromatography-atmospheric pressure chemical ionization mass spectrometry J Anal Toxicol 24 77 84 1:CAS:528:DC%2BD3cXhslOhtrg%3D 10732943
113. SP Vorce JM Holler B Levine MR Past 2008 Detection of 1-benzylpiperazine and 1-(3-trifluoromethylphenyl)-piperazine in urine analysis specimens using GC-MS and LC-ESI-MS J Anal Toxicol 32 444 450 1:CAS:528:DC%2BD1cXos12gtbg%3D 18652752
114. I Ojanperä M Gergov M Liiv A Riikoja E Vuori 2008 An epidemic of fatal 3-methylfentanyl poisoning in Estonia Int J Legal Med 122 395 400 18386033 10.1007/s00414-008-0230-x
115. JC Reepmeyer JT Woodruff 2006 Use of liquid chromatography-mass spectrometry and a hydrolytic technique for the detection and structure elucidation of a novel synthetic vardenafil designer drug added illegally to a "natural" herbal dietary supplement J Chromatogr A 1125 67 75 1:CAS:528:DC%2BD28Xns12nt7g%3D 16750214 10.1016/j.chroma.2006.05.018 (Pubitemid 44160621)
116. RD McDowall 1989 Sample preparation for biomedical analysis J Chromatogr 492 3 58 1:CAS:528:DyaL1MXlsV2lu74%3D 2670995 10.1016/S0378-4347(00)84463-1 (Pubitemid 19215493)
117. N Zhang KL Hoffman W Li DT Rossi 2000 Semi-automated 96-well liquid-liquid extraction for quantitation of drugs in biological fluids J Pharm Biomed Anal 22 131 138 10727132 10.1016/S0731-7085(99)00247-2 (Pubitemid 30089239)
118. MC Hennion 1999 Solid-phase extraction: method development, sorbents, and coupling with liquid chromatography J Chromatogr A 856 3 54 1:CAS:528:DyaK1MXmt1ent7g%3D 10526783 10.1016/S0021-9673(99)00832-8 (Pubitemid 29436006)
119. T Kamata M Nishikawa M Katagi H Tsuchihashi 2006 Direct detection of serum psilocin glucuronide by LC/MS and LC/MS/MS: time-courses of total and free (unconjugated) psilocin concentrations in serum specimens of a "magic mushroom" user Forensic Toxicol 24 36 40 1:CAS:528:DC%2BD28XpvFOiu7k%3D 10.1007/s11419-006-0006-2 (Pubitemid 44257287)
120. AF Grieshaber KA Moore B Levine 2001 The detection of psilocin in human urine J Forensic Sci 46 627 630 1:CAS:528:DC%2BD3MXktFKisLk%3D 11373000
121. T Kamata M Nishikawa M Katagi H Tsuchihashi 2003 Optimized glucuronide hydrolysis for the detection of psilocin in human urine samples J Chromatogr B 796 421 427 1:CAS:528:DC%2BD3sXosVyitrc%3D 10.1016/j.jchromb.2003.08.030 (Pubitemid 37329685)
122. T Inoue S Suzuki T Niwaguchi 1983 Stability of perfluoroacyl derivatives of methamphetamine and its metabolites (in Japanese with English abstract) Eisei Kagaku 29 412 417 1:CAS:528:DyaL2cXktFajtL8%3D
123. FT Delbeke M Debackere JA Jonckheere AP De Leenheer 1983 Pentafluorobenzoyl derivatives of doping agents: I. Extractive benzoylation and gas chromatography with electron-capture detection of primary and secondary amines J Chromatogr 273 141 149 1:CAS:528:DyaL3sXhslChsLc%3D 6853643 10.1016/S0378-4347(00)80930-5
124. P Husek 1991 Rapid derivatization and gas chromatographic determination of amino acids J Chromatogr A 552 289 299 1:CAS:528:DyaK3MXlsFCit7c%3D 10.1016/S0021-9673(01)95945-X
125. R Meatherall 1995 Rapid GC-MS confirmation of urinary amphetamine and methamphetamine as their propylchloroformate derivatives J Anal Toxicol 19 316 322 1:CAS:528:DyaK2MXnsFOqsLk%3D 7500619
126. W Birkmayer P Riederer MB Youdim 1982 (-)Deprenyl in the treatment of Parkinson's disease Clin Neuropharmacol 5 195 230 1:CAS:528:DyaL38XksV2lt7w%3D 6814755 10.1097/00002826-198205020-00004
127. Z Tarjányi H Kalász G Szebeni I Hollósi M Báthori S Fürst 1998 Gas-chromatographic study on the stereoselectivity of deprenyl metabolism J Pharm Biomed Anal 17 725 731 9682156 10.1016/S0731-7085(97)00227-6 (Pubitemid 28302698)
128. Pharmaceutical Society of Japan (ed) (2006) Standard methods of chemical analysis in poisoning with commentary, 2006-analysis, toxicity and treatment (in Japanese). Tokyo Kagaku Dojin, Tokyo